Adjuvant aromatase inhibitors
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference19 articles.
1. Tamoxifen for early breast cancer: an overview of the randomised trials
2. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
3. Trends in breast cancer incidence, survival, and mortality
4. Trends in breast cancer incidence, survival, and mortality
5. Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience;Medical Oncology;2010-12-31
2. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands;Breast Cancer Research and Treatment;2007-08-09
3. Place des inhibiteurs de l’aromatase dans le cancer du sein de la femme ménopausée, en situation adjuvante: les acquis et les incertitudes en 2005;Journal de Gynécologie Obstétrique et Biologie de la Reproduction;2006-06
4. The Role of Ovarian Ablation in the Management of Breast Cancer;The Breast Journal;2005-11
5. Controversies in the adjuvant treatment of breast cancer: new adjuvant endocrine treatment strategies;Annals of Oncology;2004-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3